Health & Nutrition

bg
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment

FDA approves Johnson & Johnson’s nasal spray for depression...

Spravato is now the first-ever standalone therapy for treatment-resistant depression,...

bg
Obesity’s Impacts on Our Immune System and Kidney and Liver Diseases 

Obesity’s Impacts on Our Immune System and Kidney and Liver...

What are the effects of weight loss on natural killer cell function, our first line...

bg
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Ozempic is in the next round of Medicare drug price negotiations....

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's...

bg
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug

Bristol Myers Squibb says Alzheimer's is the biggest market...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in...

bg
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says

Medicare's new $2,000 cap on out-of-pocket drug costs could...

The AARP report suggests the spending cap could be huge for Medicare enrollees who...

bg
Stocks pop on cool inflation, hot bank earnings — plus, new rules on biotech exports to China

Stocks pop on cool inflation, hot bank earnings — plus,...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon...

bg
Obesity’s Impacts on Gallstones, Acid Reflux, and Heart Disease 

Obesity’s Impacts on Gallstones, Acid Reflux, and Heart...

Sufficient, sustained weight loss may cut the risk of fatal heart attacks and strokes...

bg
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

Healthy Returns: From Eli Lilly to Amazon, here are the...

Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing...

bg
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand

Eli Lilly shares drop as drugmaker cuts revenue guidance...

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing...

bg
Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion

Moderna stock plunges nearly 17% after company lowers 2025...

Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion,...